FDA Inspection 1261312 - Genzyme Corporation - February 14, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Genzyme Corporation, with an inspection on February 14, 2025, issued by the New England District Office, covering biologics.

Company: Genzyme Corporation
Inspection Date: February 14, 2025
Product Type: Biologics
Office: New England District Office

Open in Dashboard

ID · abd12bcb-8957-45b8-b0a5-611ccb2bdf41

Violation Codes3

21 CFR 211.13021 CFR 211.130(d)21 CFR 211.192

Full citation text and observation details available on the Dashboard.